ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing

Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions

JERSEY CITY, NJ / ACCESS Newswire / September 16, 2025 / Apprentice.io, the creator of the first AI-powered manufacturing platform for life sciences, today announced a strategic partnership with Aprecia, the industry leader in pharmaceutical three-dimensional printing (3DP). This collaboration marks a significant step forward in digitally connected drug manufacturing, combining cutting-edge AI technology with breakthrough 3DP innovation in drug delivery.Apprecia & Apprentice Partnership Announcement

Apprecia & Apprentice Partnership Announcement

Through this partnership, Aprecia will implement Apprentice.io's intelligent manufacturing platform at its Ohio facility to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration will support Aprecia's mission to revolutionize how medications are produced and delivered using advanced additive manufacturing.

Apprentice's cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide flexibility, scalability, and connectivity appropriate for Aprecia's manufacturing model. As Aprecia continues to grow, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.

"I believe that Aprecia is the next generation of additive manufacturing," said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. "They are at the absolute forefront of innovation in life sciences. Combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future."

Aprecia's deployment of Apprentice's technology reflects a shared commitment for next level pharmaceutical manufacturing. The collaboration underscores the industry's rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.

"Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation, said Kyle Smith, president and chief operating officer at Aprecia. Our partnership with Apprentice.io strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what's possible in oral medication. We will continue to integrate cutting-edge technologies that keep us at the forefront and address the evolving needs of patients and caregivers."

About Aprecia

Aprecia has brought significant change to pharmaceutical manufacturing with advanced 3D printing technology, enhancing the speed, flexibility, and precision of oral medication production. Through strategic partnerships, Aprecia can create personalized medicine and accelerate market entry, setting new standards in the industry.

Located in Mason, Ohio, Aprecia's capabilities include pharmaceutical manufacturing, drug product development, engineering innovation, and analytical methods. For over 20 years, Aprecia has led in pharmaceutical additive manufacturing technologies, establishing 3D printing as a viable pharmaceutical manufacturing option and is continuously exploring ways to improve medicine and patient health outcomes. For more information, visit www.aprecia.com.

About Apprentice

Apprentice is the industry's first agentic manufacturing platform built for a world beyond paper and legacy MES. Apprentice unifies MES, LES, automation, and remote collaboration capabilities together in a modern, no-code platform while simultaneously deploying AI Agents to support every step of manufacturing. The AI Agents operate autonomously to amplify human efforts, optimize processes, and scale throughput while reducing costs. The company's technology drives innovation at every stage-from design and creation to simulation, execution, and optimization. For over a decade, we've helped life sciences companies integrate their people, processes, and systems into a single next-gen platform. Today, Apprentice serves all manufacturing sectors fulfilling the vision of what a digital "Apprentice" can be. For more information, visit www.apprentice.io.

Contact Information:

Kristen Kucks
Director of Communications, Marketing
kristen.kucks@apprentice.io

Justin Foreman
justin.foreman@apprentice.io

.

SOURCE: Apprentice.io



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.